Interactive Financial Charts Not Available

Sanofi Consumer (SANOFICONR) | Financial Analysis & Statements

Sanofi Consumer Healthcare Inc. | Mid-cap | Healthcare

₹5,180.70

0.00%

Sanofi Consumer vs GlaxoSmithKline Sanofi Consumer vs Pfizer Sanofi Consumer vs Sanofi India Limited Sanofi Consumer vs Marksans Pharma Sanofi Consumer vs Senores Sanofi Consumer vs NIFTY 50 | Market

TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 1.7B

Gross Profit 1.3B 77.52%

Operating Income 620.0M 35.92%

Net Income 500.0M 28.97%

EPS (Diluted) ₹21.69

Balance Sheet Metrics

Total Assets 4.3B

Total Liabilities 1.6B

Shareholders Equity 2.7B

Debt to Equity 0.58

Cash Flow Metrics

Revenue & Profitability Trend

Interactive Financial Charts Not Available

This page uses interactive financial charts and dynamic data visualization tools that require JavaScript. For detailed financial analysis:

Available Financial Data:

Income statements (annual and quarterly)
Balance sheets with asset and liability details
Cash flow statements and free cash flow analysis
Key financial ratios and performance metrics
Peer comparison and industry benchmarking

All financial data is displayed in accessible table format below. Use the table headers and structure to analyze trends and compare metrics across different periods.

Sanofi Consumer Income Statement From 2023 to 2024

Metric	2024	2023
Revenue i	7.2B	5.4B
Cost of Goods Sold i	2.3B	1.9B
Gross Profit i	4.9B	3.5B
Gross Margin % i	68.1%	64.4%
Operating Expenses
Research & Development i	-	-
Selling, General & Administrative i	724.0M	647.0M
Other Operating Expenses i	472.0M	231.0M
Total Operating Expenses i	1.2B	878.0M
Operating Income i	2.7B	2.2B
Operating Margin % i	37.2%	39.9%
Non-Operating Items
Interest Income i	109.0M	40.0M
Interest Expense i	40.0M	2.0M
Other Non-Operating Income	-	-
Pre-tax Income i	2.5B	2.2B
Income Tax i	658.0M	544.0M
Effective Tax Rate % i	26.7%	24.8%
Net Income i	1.8B	1.6B
Net Margin % i	25.3%	30.3%
Key Metrics
EBITDA i	2.8B	2.2B
EPS (Basic) i	₹78.59	₹71.60
EPS (Diluted) i	₹78.59	₹71.60
Basic Shares Outstanding i	23030622	23030622
Diluted Shares Outstanding i	23030622	23030622

Income Statement Trend

Sanofi Consumer Balance Sheet From 2023 to 2024

Metric	2024	2023
Assets
Current Assets
Cash & Equivalents i	3.3B	16.0M
Short-term Investments i	38.0M	-
Accounts Receivable i	137.0M	316.0M
Inventory i	409.0M	966.0M
Other Current Assets	58.0M	-
Total Current Assets i	3.9B	3.4B
Non-Current Assets
Property, Plant & Equipment i	272.0M	0
Goodwill i	19.0M	55.0M
Intangible Assets i	19.0M	55.0M
Long-term Investments	-	-
Other Non-Current Assets	-	-
Total Non-Current Assets i	396.0M	102.0M
Total Assets i	4.3B	3.5B
Liabilities
Current Liabilities
Accounts Payable i	703.0M	600.0M
Short-term Debt i	37.0M	0
Current Portion of Long-term Debt	-	-
Other Current Liabilities	39.0M	-
Total Current Liabilities i	1.3B	1.3B
Non-Current Liabilities
Long-term Debt i	166.0M	0
Deferred Tax Liabilities i	-	-
Other Non-Current Liabilities	-	-
Total Non-Current Liabilities i	277.0M	79.0M
Total Liabilities i	1.6B	1.4B
Equity
Common Stock i	230.0M	20.0M
Retained Earnings i	-	-
Treasury Stock i	-	-
Other Equity	-	-
Total Shareholders Equity i	2.7B	2.1B
Key Metrics
Total Debt i	203.0M	0
Working Capital i	2.6B	2.1B

Balance Sheet Composition

Sanofi Consumer Cash Flow Statement From 2023 to 2024

Metric	2024	2023
Operating Activities
Net Income i	2.5B	2.2B
Depreciation & Amortization i	-	-
Stock-Based Compensation i	10.0M	0
Working Capital Changes i	2.9B	-2.2B
Operating Cash Flow i	5.3B	-55.0M
Investing Activities
Capital Expenditures i	-99.0M	-40.0M
Acquisitions i	-	-
Investment Purchases i	-	-
Investment Sales i	-	-
Investing Cash Flow i	-99.0M	-40.0M
Financing Activities
Share Repurchases i	-	-
Dividends Paid i	-1.2B	-
Debt Issuance i	-	-
Debt Repayment i	-	-
Financing Cash Flow i	-1.2B	20.0M
Free Cash Flow i	4.3B	-44.0M
Net Change in Cash i	4.1B	-75.0M

Cash Flow Trend

Sanofi Consumer Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 59.52

Forward P/E 43.03

Price to Book 46.42

Price to Sales 16.48

PEG Ratio 6.10

Profitability Ratios

Profit Margin 27.62%

Operating Margin 30.42%

Return on Equity 66.30%

Return on Assets 41.97%

Financial Health

Current Ratio 2.76

Debt to Equity 11.01

Per Share Data

EPS (TTM) ₹87.04

Book Value per Share ₹111.61

Revenue per Share ₹314.41

Peer Financial Comparison

Company	Market Cap	P/E Ratio	P/B Ratio	ROE	Profit Margin	Debt/Equity
sanoficonr	119.3B	59.52	46.42	66.30%	27.62%	11.01
GlaxoSmithKline	453.6B	47.75	23.25	47.54%	25.41%	0.51
Pfizer	229.7B	29.76	5.42	19.65%	33.65%	2.57
Sanofi India Limited	123.5B	33.06	15.33	49.43%	18.29%	2.67
Marksans Pharma	97.1B	25.55	3.94	16.73%	14.51%	12.93
Senores	30.0B	44.41	3.88	7.21%	14.82%	38.75

Financial data is updated regularly. All figures are in the company's reporting currency.